Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
January 11, 2024
Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches
C Llacer-Moscardo, L Moureau-Zabotto, L Ollivier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
L Ferretti, M Gross-Goupil, P Sargos, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendations
J Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]
I Latorzeff, P Sargos, G Créhange, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
February 7, 2022
[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology]
G Ploussard, J-B Beauval, R Mathieu, et al.
Actas Urologicas Espanolas
|
April 4, 2024
Is trimodal therapy the current standard for muscle-invasive bladder cancer?
M López Valcárcel, M Barrado Los Arcos, M Ferri Molina, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 1, 2022
[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]
M Baboudjian, J-B Beauval, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
January 31, 2023
Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patients
M Lasserre, P Sargos, E Barret, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer
I Latorzeff, A Camps-Maléa, S Supiot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance
G Ploussard, G Roubaud, E Barret, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
January 11, 2024
Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches
C Llacer-Moscardo, L Moureau-Zabotto, L Ollivier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 7, 2015
[Not Available]
L Ferretti, M Gross-Goupil, P Sargos, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
April 10, 2018
Dose constraints for moderate hypofractionated radiotherapy for prostate cancer: The French genito-urinary group (GETUG) recommendations
J Langrand-Escure, R de Crevoisier, C Llagostera, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]
I Latorzeff, P Sargos, G Créhange, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
February 7, 2022
[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology]
G Ploussard, J-B Beauval, R Mathieu, et al.
Actas Urologicas Espanolas
|
April 4, 2024
Is trimodal therapy the current standard for muscle-invasive bladder cancer?
M López Valcárcel, M Barrado Los Arcos, M Ferri Molina, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 1, 2022
[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]
M Baboudjian, J-B Beauval, E Barret, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
January 31, 2023
Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patients
M Lasserre, P Sargos, E Barret, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
October 12, 2023
Indication and perspectives of radiation therapy in the setting of de-novo metastatic prostate cancer
I Latorzeff, A Camps-Maléa, S Supiot, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 18, 2022
French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance
G Ploussard, G Roubaud, E Barret, et al.
Page
of 8